{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:30:08Z","timestamp":1794051008368,"version":"4.8.0"},"reference-count":109,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Global Infect Dis"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0974-777x.68531","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T07:56:09Z","timestamp":1283327769000},"page":"263","source":"Crossref","is-referenced-by-count":500,"title":["Extended-spectrum \u00df-lactamases in gram negative bacteria"],"prefix":"10.4103","volume":"2","author":[{"given":"Deepti","family":"Rawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthi","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-777X.68531-1","first-page":"1131","volume-title":"Extended-spectrum beta-lactamases","author":"Philippon","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-2","first-page":"657","volume-title":"Extended-spectrum \u03af-lactamases: A clinical update","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0974-777X.68531-3","first-page":"52","volume-title":"Emergence of Enterobacteriaceae producing extended-spectrum \u03af-lactamases (ESBLs) in the community","author":"Pitout","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-4","doi-asserted-by":"crossref","unstructured":"Doi Y, Adams J, O\u2032Keefe A, Quereshi Z, Ewan L, Paterson DL. Community-acquired extended-spectrum b-lactamase producers, United States [letter]. Emerg Infect Dis [serial on the Internet]. Available from: http:\/\/www.cdc.gov\/EID\/content\/13\/7\/1121.htm [last cited on 2007].","DOI":"10.3201\/eid1307.070094"},{"key":"key-10.4103\/0974-777X.68531-5","first-page":"460","volume-title":"Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum \u03af-lactamases (ESBLs)","author":"Paterson","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"key-10.4103\/0974-777X.68531-6","first-page":"71","volume-title":"Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe","author":"Mammeri","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-7","first-page":"1295","volume-title":"Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States","author":"Wang","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-8","unstructured":"Livermoore DM, Paterson DL. Pocket guide to extended spectrum \u03af-lactamases in resistance. New Delhi: Springer (India) Private Limited; 2006."},{"key":"key-10.4103\/0974-777X.68531-9","first-page":"269","volume-title":"A standard numbering scheme for the class A beta-lactamases","author":"Ambler","year":"1991","journal-title":"Biochem J"},{"key":"key-10.4103\/0974-777X.68531-10","first-page":"1211","volume-title":"A functional classification scheme for beta-lactamases and its correlation with molecular structure","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-11","first-page":"223","volume-title":"Carbapenem-hydrolyzing beta-lactamases","author":"Rasmussen","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-12","first-page":"585","volume-title":"Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during therapy","author":"Chow","year":"1991","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0974-777X.68531-13","first-page":"185","volume-title":"Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species","author":"Cosgrove","year":"2002","journal-title":"Arch Intern Med"},{"key":"key-10.4103\/0974-777X.68531-14","first-page":"2628","volume-title":"Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp","author":"Kaye","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-15","first-page":"57","volume-title":"In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases","author":"Sanders","year":"1996","journal-title":"J Chemother"},{"key":"key-10.4103\/0974-777X.68531-16","first-page":"527","volume-title":"Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units","author":"Yuan","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-17","first-page":"1960","volume-title":"Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan","author":"Wachino","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-18","first-page":"933","volume-title":"Extended-spectrum-lactamases in the 21 st century: Characterization, epidemiology, and detection of this important resistance threat","author":"Bradford","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0974-777X.68531-19","first-page":"3402","volume-title":"Sequence-selective recognition of extended-spectrum beta-lactamase GES-2 by a competitive, peptide nucleic acid-based multiplex PCR assay","author":"Weldhagen","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-20","first-page":"557","volume-title":"Beta-lactamases in laboratory and clinical resistance","author":"Livermore","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0974-777X.68531-21","first-page":"1362","volume-title":"OXA-17, a further extended-spectrum variant of OXA-10 beta-lactamase, isolated from Pseudomonas aeruginosa","author":"Danel","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-22","first-page":"1881","volume-title":"OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa","author":"Danel","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-23","first-page":"785","volume-title":"OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain","author":"Danel","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-24","first-page":"3117","volume-title":"OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates","author":"Danel","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-25","first-page":"1637","volume-title":"OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa","author":"Hall","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-26","first-page":"2859","volume-title":"Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d\u2032 beta-lactamase in Pseudomonas aeruginosa","author":"Toleman","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-27","first-page":"616","volume-title":"Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase","author":"Bauernfeind","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-28","first-page":"104","volume-title":"Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases","author":"Nordmann","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-29","first-page":"3061","volume-title":"A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil","author":"Bonnet","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-30","first-page":"2247","volume-title":"IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain","author":"Giakkoupi","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-31","first-page":"307","volume-title":"Characterization of SFO-1, a plasmid-mediated inducible class A beta-lactamase from Enterobacter cloacae","author":"Matsumoto","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-32","first-page":"627","volume-title":"An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1","author":"Mavroidi","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-33","first-page":"622","volume-title":"Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae","author":"Poirel","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-34","first-page":"573","volume-title":"Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene","author":"Poirel","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-35","first-page":"2598","volume-title":"GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem","author":"Poirel","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-36","first-page":"997","volume-title":"TLA-1: A new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli","author":"Silva","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-37","first-page":"2965","volume-title":"Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis","author":"Bellais","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-38","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Nineteeneth Informational Supplement. CLSI document M100-S19. Wayne PA: Clinical and Laboratory Standards Institute; 2009."},{"key":"key-10.4103\/0974-777X.68531-39","first-page":"2864","volume-title":"Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods","author":"Steward","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-40","first-page":"867","volume-title":"ESBLs conferring transferable resistance to newer-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns","author":"Jarlier","year":"1988","journal-title":"Rev Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-41","first-page":"269","volume-title":"Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using National Committee for Clinical Laboratory Standards ESBL methodology","author":"Queenan","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-42","first-page":"24","volume-title":"Comparison of five different methods for detection of SHV extended-spectrum beta-lactamases","author":"Randegger","year":"2001","journal-title":"J Chemother"},{"key":"key-10.4103\/0974-777X.68531-43","first-page":"49","volume-title":"Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae","author":"Ho","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-44","first-page":"715","volume-title":"Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection","author":"MacKenzie","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"key-10.4103\/0974-777X.68531-45","first-page":"1877","volume-title":"Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: Comparison of the double-disk and three-dimensional tests","author":"Thomson","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-46","first-page":"2191","volume-title":"Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp.in a Belgian teaching hospital","author":"Vercauteren","year":"1997","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-47","first-page":"113","volume-title":"Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates","author":"Revathi","year":"1997","journal-title":"Indian J Med Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0255-0857","issn-type":"print"},{"key":"key-10.4103\/0974-777X.68531-48","first-page":"493","volume-title":"Aztreonam-clavulanic acid synergy does not mean extended-spectrum beta-lactamase in Stenotrophomonas maltophilia","author":"Munoz","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-49","first-page":"881","volume-title":"Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: Comparison of the MAST DD test, the double disc and the Etest ESBL","author":"M\u2032Zali","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-50","first-page":"2997","volume-title":"Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test","author":"Sanders","year":"1996","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-51","first-page":"1880","volume-title":"Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen","author":"Cormican","year":"1996","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-52","first-page":"125","volume-title":"Evaluation of MicroScan ESBL confirmation panel for Enterobacteriaceae-producing, extended-spectrum beta-lactamases isolated in Japan","author":"Komatsu","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-53","first-page":"1549","volume-title":"Emerging extended-spectrum beta-lactamases in Proteus mirabilis","author":"Pagani","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-54","first-page":"1419","volume-title":"Extended-spectrum beta-lactamases: A call for improved detection and control","author":"Paterson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-55","first-page":"3703","volume-title":"Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp","author":"Leverstein-van","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-56","first-page":"1463","volume-title":"Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method","author":"Sanguinetti","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-57","first-page":"29","volume-title":"Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates","author":"Sturenburg","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-58","first-page":"535","volume-title":"Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction","author":"Miro","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-59","first-page":"89","volume-title":"Does high level production of SHV-type penicillinase confer resistance to ceftazidime in Enterobacteriaceae?","author":"Petit","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"key-10.4103\/0974-777X.68531-60","first-page":"362","volume-title":"High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae","author":"Rice","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-61","first-page":"2388","volume-title":"Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate","author":"Tzouvelekis","year":"1999","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-62","first-page":"2061","volume-title":"Detection and clinical significance of ES Ls in a tertiary - care medical center","author":"Emery","year":"1997","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-63","first-page":"920","volume-title":"ESBLs: Epidemiology, detection and treatment","author":"Nathisuwan","year":"2001","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0974-777X.68531-64","first-page":"2593","volume-title":"Occurrence and detection of ESBL in members of the family Enterobacteriacieae at a veterans medical center: Seek and you may find","author":"Coudron","year":"1997","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-65","first-page":"1187","volume-title":"In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp.resistant to oxyimino cephalosporins","author":"Jett","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-66","first-page":"S49","volume-title":"Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: Effect of large inocula","author":"Medeiros","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.4103\/0974-777X.68531-67","first-page":"1243","volume-title":"Efficacy of different beta-lactams against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain in the rat intra-abdominal abscess model","author":"Rice","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-68","first-page":"1053","volume-title":"Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae","author":"Thauvin-Eliopoulos","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-69","first-page":"55","volume-title":"Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection","author":"Asensio","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-70","first-page":"529","volume-title":"Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiologic investigation","author":"Schiappa","year":"1996","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-71","first-page":"35","volume-title":"Molecular detection of GES-2 extended spectrum beta-lactamase producing Pseudomonas aeruginosa in Pretoria, South Africa","author":"Weldhagen","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.68531-72","first-page":"430","volume-title":"Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition","author":"Lucet","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-73","first-page":"9","volume-title":"Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit","author":"Pena","year":"1997","journal-title":"J Hosp Infect"},{"key":"key-10.4103\/0974-777X.68531-74","first-page":"441","volume-title":"Concomitant dissemination of three extended-spectrum beta-lactamases among different Enterobacteriaceae isolated in a French hospital","author":"de","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-75","doi-asserted-by":"crossref","unstructured":"Crowley BD. Extended-spectrum beta-lactamases in blood culture isolates of Klebsiella pneumoniae: Seek and you may find! J Antimicrob Chemother 2001;47:728-9.","DOI":"10.1093\/oxfordjournals.jac.a002696"},{"key":"key-10.4103\/0974-777X.68531-76","first-page":"504","volume-title":"A 5-year epidemiological study of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit","author":"Mangeney","year":"2000","journal-title":"J Appl Microbiol"},{"key":"key-10.4103\/0974-777X.68531-77","first-page":"21","volume-title":"Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia","author":"Ariffin","year":"2000","journal-title":"Int J Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-78","first-page":"1162","volume-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-79","first-page":"1718","volume-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: Risk factors and clinical outcome","author":"Du","year":"2002","journal-title":"Intensive Care Med"},{"key":"key-10.4103\/0974-777X.68531-80","first-page":"155","volume-title":"Antimicrobial use prior to the acquisition of multiresistant bacteria","author":"Eveillard","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.4103\/0974-777X.68531-81","first-page":"567","volume-title":"Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: A case-control study of risk factors and outcomes","author":"Ho","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-82","first-page":"99","volume-title":"Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia","author":"Kim","year":"2002","journal-title":"J Hosp Infect"},{"key":"key-10.4103\/0974-777X.68531-83","first-page":"1481","volume-title":"Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome","author":"Kim","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-84","doi-asserted-by":"crossref","unstructured":"Lee SO, Lee ES, Park SY, Kim SY, Seo Y, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004;25:832-7,","DOI":"10.1086\/502304"},{"key":"key-10.4103\/0974-777X.68531-85","first-page":"26","volume-title":"International prospective study of Klebsiella pneumoniae bacteremia: Implications of extended-spectrum beta-lactamase production in nosocomial infections","author":"Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0974-777X.68531-86","first-page":"198","volume-title":"Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors for infection and colonization","author":"Pessoa-Silva","year":"2003","journal-title":"J Hosp Infect"},{"key":"key-10.4103\/0974-777X.68531-87","first-page":"20","volume-title":"ESBL-From petri dish to the patient","author":"Bhattacharya","year":"2006","journal-title":"Indian J Med Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0255-0857","issn-type":"print"},{"key":"key-10.4103\/0974-777X.68531-88","first-page":"559","volume-title":"Prevalence of plasmid-mediated quinolone resistance","author":"Jacoby","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-89","first-page":"71","volume-title":"Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe","author":"Mammeri","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-90","first-page":"797","volume-title":"Quinolone resistance from a transferable plasmid","author":"Martinez-Martinez","year":"1998","journal-title":"Lancet"},{"key":"key-10.4103\/0974-777X.68531-91","first-page":"790","volume-title":"Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: Prevalence of CTX-M-3 at a hospital in China","author":"Wang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-92","first-page":"183","volume-title":"Antimicrobial resistance amongst Klebsiella spp.collected from intensive care units in Southern and Western Europe in 1997-1998","author":"Babini","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-93","first-page":"64","volume-title":"Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe","author":"Brisse","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-94","first-page":"1288","volume-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-95","first-page":"473","volume-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","author":"Paterson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-96","first-page":"243","volume-title":"Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: Treatment outcome of patients receiving imipenem or ciprofloxacin","author":"Endimiani","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-97","first-page":"31","volume-title":"Antibiotic therapy for Klebsiella pneumoniae bacteremia: Implications of production of extended-spectrum beta-lactamases","author":"Paterson","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-98","first-page":"75","volume-title":"Extended spectrum \u03af lactamases (ESBL) - An emerging threat to clinical therapeutics","author":"Chaudhary","year":"2004","journal-title":"Indian J Med Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0255-0857","issn-type":"print"},{"key":"key-10.4103\/0974-777X.68531-99","first-page":"1209","volume-title":"Recent developments in \u03af lactamases and extended spectrum \u03af lactamases","author":"Samaha-Kfoury","year":"2003","journal-title":"BMJ"},{"key":"key-10.4103\/0974-777X.68531-100","first-page":"512","volume-title":"Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae","author":"Akhan","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-101","first-page":"3548","volume-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-102","first-page":"131","volume-title":"In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria","author":"Rawat","year":"2009","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"key-10.4103\/0974-777X.68531-103","first-page":"538","volume-title":"Etrapenam, the first of a new group of carbapenems","author":"Shah","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.68531-104","first-page":"455","volume-title":"Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae","author":"Patterson","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key-10.4103\/0974-777X.68531-105","first-page":"76","volume-title":"Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: Are beta-lactamase inhibitors of therapeutic value?","author":"Piroth","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-106","first-page":"118","volume-title":"Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center","author":"Rice","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.68531-107","first-page":"1095","volume-title":"Two different extended-spectrum beta-lactamases (ESBLs) in one of the first ESBL-producing Salmonella isolates in Poland","author":"Baraniak","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-777X.68531-108","first-page":"761","volume-title":"Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate","author":"Bradford","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.68531-109","first-page":"630","volume-title":"Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People\u2032s Republic of China","author":"Chanawong","year":"2002","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:55:53Z","timestamp":1786632953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-777X.68531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["68531"],"URL":"https:\/\/doi.org\/10.4103\/0974-777x.68531","relation":{},"ISSN":["0974-777X"],"issn-type":[{"value":"0974-777X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}